PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Aggressive brain tumor mapped in genetic, molecular detail

Glioblastoma study could lead to new treatments, including better immunotherapies

Aggressive brain tumor mapped in genetic, molecular detail
2021-02-11
(Press-News.org) Glioblastoma is among the most aggressive and devastating of cancers. While rare compared with other cancers, it's the most common type of brain cancer. Even with intensive therapy, relatively few patients survive longer than two years after diagnosis, and fewer than 10% of patients survive beyond five years. Despite extensive studies focused on genomic features of glioblastoma, relatively little progress has been made in improving treatment for patients with this deadly disease.

Now, a new study led by Washington University School of Medicine in St. Louis, Pacific Northwest National Laboratory, Case Western Reserve University and the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has revealed a detailed map of the genes, proteins, infiltrating cells and signaling pathways that play key roles in driving glioblastoma. The study, of 99 tumors from patients, is the largest and most detailed schematic of this deadly brain tumor.

The research, published Feb. 11 in the journal Cancer Cell, is part of the NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC).

"To improve therapies for this deadly cancer, understanding the tumor cells themselves is important but not enough," said senior author Li Ding, PhD, a professor of medicine and of genetics and director of computational biology in the Division of Oncology at Washington University. "We also must understand the tumor cells' interactions with the surrounding environment, including immune cells and the connective tissues and blood vessels. In our study, we performed high-resolution and high-depth analyses on 99 glioblastoma tumors. Harnessing new technologies, including proteomics, metabolomics and single cell sequencing, this study is an extremely deep dive into glioblastoma tumor biology, revealing new possibilities for therapy."

The study identified new activated proteins -- particularly PTPN11 and PLCG1 -- that serve as signaling hubs driving tumor growth in some patients; revealed gene expression patterns involved in a process called epithelial-to-mesenchymal transition that is common in tumor formation; identified four different categories by which to classify glioblastoma, based on the number and types of immune cells present in the tumors; and determined how an understudied protein modification, acetylation, may explain some functional differences between glioblastoma subtypes.

"Acetylation changes a protein's shape and often results in opening up DNA-protein complexes to facilitate gene expression. By adding protein acetylation to our study, we were able to complete the loop from proteins to genes and gene expression, shedding light on important regulatory changes in glioblastoma," said co-senior author Karin Rodland, PhD, chief scientist for biomedical research at Pacific Northwest National Laboratory.

"The most immediate implications for these findings are better design of clinical trials," said co-author Milan G. Chheda, MD, an assistant professor of medicine who treats patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. "For most clinical trials, we take all comers and give them the same treatment. We are not designing trials in the most precise way because we have not fully understood the molecular differences between each patient's tumor. This leads us to call a treatment a failure when in fact it may be helping specific people."

The new study demonstrates that individual tumors are likely to respond differently to targeted therapies. For example, the immune landscape of these tumors varied widely, fitting into four separate categories. Type 1 tumors contain high numbers of immune cells called macrophages and a few T cells. Type 2 tumors have a moderate number of macrophages. Type 3 tumors include high numbers of T cells and a few macrophages. And type 4 tumors are what Ding calls an immune desert, with few or no immune cells of any type. So, an immunotherapy that targets macrophages, for example, might work well in patients with type 1 tumors but not at all in patients with type 4. Still, a clinical trial that lumps all patients together may not show such a drug works at all, when averaged across all patients.

"What's especially appealing about this study is the clustering of glioblastoma into four groups based on immune subtypes that emerged by combining proteomic and genomic comprehensive analysis," said Henry Rodriguez, director of the Office of Cancer Clinical Proteomics Research at the NCI. "This may open the door for effective responses to immune therapies."

Added co-author Albert H. Kim, MD, PhD, a professor of neurological surgery at Washington University and director of the Brain Tumor Center at Siteman: "Immunotherapy clinical trials in glioblastoma have been negative so far. And the fact that there are four different immune subgroups may be one of the reasons behind that. We can't treat all glioblastoma tumors as one disease."

A group led by co-senior author Tao Liu, PhD, of Pacific Northwest National Laboratory, measured all of the proteins in the tumor samples as well as two specific modifications, called phosphorylation and acetylation, that affect biological functions such as cell signaling. Adding these data into the genomic analysis of the tumors revealed a small subset of glioblastomas that did not fit neatly into any of the typical genomic subtypes. These mixed-subtype tumors were associated with a poor clinical outcome, providing the researchers with clues to the factors affecting the aggressiveness of a tumor that were not evident from genetic information alone.

"These patterns provide additional information for researchers to understand how the glioblastoma subtypes they identified may vary in biological function," Liu said. "This multifaceted analysis provides an unprecedented level of detail, which is starting to connect the missing dots in glioblastoma."

Added Chheda, "This paper is an example of the advances that can be made when there is deep collaboration between many experts across the country who the National Cancer Institute has the ability to bring together."

The researchers are conducting further studies to identify the best drugs to investigate in glioblastoma patients, depending on where their diseases fall on the new tumor map.

INFORMATION:

The study's co-first authors are Liang-Bo Wang, a doctoral student in Ding's lab; Alla Karpova, a doctoral student in Ding's lab; Song Cao, PhD, an instructor in medicine; and Yize Li, a doctoral student in Ding's lab, all of Washington University School of Medicine; and Marina A. Gritsenko, and Jennifer E. Kyle, PhD, both of Pacific Northwest National Laboratory.

This work was supported by the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium of the NIH, grant numbers U24CA210972, U24CA210955, U24CA210954, U24CA210985, U24CA210993, U24CA210967, U24CA210986, U01CA214125, and U24CA210979; the National Human Genome Research Institute, grant number R01HG009711; and the NIH, grant number R01NS107833. The MS-based Q12 proteomics work was performed at the Environmental Molecular Sciences Laboratory (grid.436923.9), a U.S. Department of Energy National Scientific User Facility at the Pacific Northwest National Laboratory operated under contract DE-AC05-76RL01830.

Wang L, et al. for the Clinical Proteomic Tumor Analysis Consortium. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell. Feb. 11, 2021.

Washington University School of Medicine's 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.


[Attachments] See images for this press release:
Aggressive brain tumor mapped in genetic, molecular detail

ELSE PRESS RELEASES FROM THIS DATE:

SARS-CoV-2 screening using CRISPR-based methods

2021-02-11
What The Study Did: This observational study assessed CRISPR-based methods for screening to detect SARS-CoV-2 among asymptomatic college students. Authors: Carolina Arias, Ph.D., of the University of California, Santa Barbara, is the corresponding author. To access the embargoed study:  Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamanetworkopen.2020.37129) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: ...

National trends in us otolaryngology surgical volume early in COVID-19 pandemic

2021-02-11
What The Study Did: Changes in otolaryngology surgical volumes in the United States early on in the COVID-19 pandemic are described in this study. Authors: Anirudh Saraswathula, M.D., M.S., of Johns Hopkins University School of Medicine in Baltimore, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoto.2020.5472) Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest ...

Pragmatic solutions to counteract regressive effects of COVID-19 pandemic for women in academic oncology

2021-02-11
What The Viewpoint Says: How pandemic-related disruptions may adversely impact progress toward a gender-balanced workforce in academic oncology is described in this article, which also offers possible solutions to mitigate the problem in this specialty. Authors: Reshma Jagsi, M.D., D.Phil., of the University of Michigan in Ann Arbor, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoncol.2020.7681) Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media ...

How do our memories take shape?

How do our memories take shape?
2021-02-11
Your brain is constantly evaluating which aspects of your experiences to either remember for later, ignore, or forget. Dartmouth researchers have developed a new approach for studying these aspects of memory, by creating a computer program that turns sequences of events from a video into unique geometric shapes. These shapes can then be compared to the shapes of how people recounted the events. The study provides new insight into how experiences are committed to memory and recounted to others. The results are published in Nature Human Behavior and were based on how people remembered the experience of watching an episode of Sherlock, a BBC television show. "When we represent experiences and memories as shapes, we can use the tools ...

Study identifies never-before-seen dual function in enzyme critical for cancer growth

2021-02-11
Considered the most lethal form of DNA damage, double-strand breaks must be repaired to prevent cell death. In developing therapies for hard-to-treat breast and ovarian cancers in patients with BRCA gene mutations, scientists aim to identify ways to keep cancer cells from using DNA break repair pathways. New findings demonstrate a previously-unknown capability for polymerase theta (pol theta) - a key enzyme in this repair function - that shows promise as a new avenue for treatment development. The study results are published in Molecular Cell. Researchers at the University of Vermont (UVM), The University of Texas MD Anderson ...

Protected areas see continued deforestation but at a reduced rate, OSU research shows

Protected areas see continued deforestation but at a reduced rate, OSU research shows
2021-02-11
CORVALLIS, Ore. - A survey of more than 18,000 land parcels spanning 2 million square miles across 63 countries shows that a "protected area" designation reduces the rate of deforestation but does not prevent it. Published today in Nature Ecology and Evolution, the findings are important because most terrestrial species live in forests and because the study suggests that just 6.5% of the Earth's woodlands are truly protected, well below the 2020 target of 17% set by the United Nations' Convention on Biological Diversity. The findings are also timely given President Biden's recent executive order on climate change, which calls for protecting 30% of the United States' ...

Vaporised crusts of Earth-like planets found in dying stars

Vaporised crusts of Earth-like planets found in dying stars
2021-02-11
Observations of lithium and potassium around white dwarf stars point to remains of rocky planet crusts Analysis by astronomers led by University of Warwick shows chemical composition of crusts is very similar to Earth's continental crust The outer layers of the white dwarfs contain up to 300,000 gigatonnes of rocky debris, which includes up to 60 gigatonnes of lithium and 3,000 gigatonnes of potassium These white dwarfs are among the oldest stars in our galaxy, and could host one of the oldest planetary systems discovered so far Remnants of planets with Earth-like crusts have been discovered in the atmospheres of four nearby white dwarf stars by University of Warwick astronomers, offering a glimpse of the planets that may have once orbited ...

Nightly sleep of five hours, less, may increase risk of dementia, death among older adults

2021-02-11
BOSTON -- Sleep and health are inextricably connected. New research from investigators at Brigham and Women's Hospital explores the connection between sleep disturbances and deficiencies among older adults and risk of dementia and death, finding that risk of dementia was double among participants who reported getting less than five hours of sleep compared to those who reported 7-8 hours of sleep per night. The team also found associations between sleep disturbance and sleep deficiency with overall risk of death. Results are published in Aging. "Our findings illuminate a connection between sleep deficiency and risk of dementia and confirm the importance of efforts to help older individuals obtain ...

Combination of pine scent and ozone as super source of particulate emissions

2021-02-11
Combination of pine scent and ozone as super source of particulate emissions from coniferous forests Scientists have managed to figure out why conifer forests produce so many fine particles into the atmosphere. Aerosol particles are particularly abundant when ?-pinene, the molecule responsible for the characteristic pattern of pine trees reacts with atmospheric ozone. Atmospheric aerosol particles affect the Earth's climate by forming clouds, but at the same time they also pollute the air, thereby increasing mortality. Aerosol particles in the atmosphere have their origins in many sources. The significant amount of aerosol particles in the atmosphere is caused ...

TalTech scientists developed novel immune diagnostics of multiple sclerosis

TalTech scientists developed novel immune diagnostics of multiple sclerosis
2021-02-11
Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) as the presenting symptom, but not all ON patients develop MS. The TalTech gene technology research unit, in collaboration with the laboratory of Protobios OÜ and medical researchers of the University of Helsinki, published their findings in the prestigious journal of EBioMedicine entitled "Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients". The lead author Helle Sadam and co-authors Mariliis Jaago and Annika ...

LAST 30 PRESS RELEASES:

Antidepressant shows promise for treating brain tumors

European Green Deal: a double-edged sword for global emissions

Walking in lockstep

New blood test could be an early warning for child diabetes

Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away

Analysis sheds light on COVID-19-associated disease in Japan

Cooler heads prevail: New research reveals best way to prevent dogs from overheating

UC Riverside medical school develops new curriculum to address substance use crisis

Food fussiness a largely genetic trait from toddlerhood to adolescence

Celebrating a century of scholarship: Isis examines the HSS at 100

Key biomarkers identified for predicting disability progression in multiple sclerosis

Study: AI could lead to inconsistent outcomes in home surveillance

Study: Networks of Beliefs theory integrates internal & external dynamics

Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed

Major $21 million Australian philanthropic investment to bring future science into disease diagnosis

Innovating alloy production: A single step from ores to sustainable metals

New combination treatment brings hope to patients with advanced bladder cancer

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

UTIA researchers win grant for automation technology for nursery industry

Can captive tigers be part of the effort to save wild populations?

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled

Study: Proteins in tooth enamel offer window into human wellness

New cancer cachexia treatment boosts weight gain and patient activity

Rensselaer researcher receives $3 million grant to explore gut health

Elam named as a Fellow of the Electrochemical Society

Study reveals gaps in access to long-term contraceptive supplies

Shining a light on the roots of plant “intelligence”

Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections

Pushing kidney-stone fragments reduces stones’ recurrence

[Press-News.org] Aggressive brain tumor mapped in genetic, molecular detail
Glioblastoma study could lead to new treatments, including better immunotherapies